Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
04/2011
04/12/2011CA2592367C Novel cyclohexane derivatives
04/12/2011CA2528496C Acylated amino acid amidyl pyrazoles and related compounds
04/12/2011CA2490987C Process for the preparation of phenyl pyrazole compounds
04/12/2011CA2471099C .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors
04/07/2011WO2011040510A1 Indazole analogue
04/07/2011WO2011038579A1 Compounds and compositions as protein kinase inhibitors
04/07/2011WO2011038572A1 Novel compounds
04/07/2011WO2010051926A8 Novel halogen-substituted compounds
04/07/2011US20110082143 Bicyclic Heteroaryl Compounds
04/07/2011US20110082141 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
04/07/2011US20110081312 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
04/07/2011US20110081297 Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles
04/07/2011CA2775753A1 Novel compounds
04/07/2011CA2775464A1 Indazole analog
04/06/2011EP2305640A2 Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases
04/06/2011EP2305033A1 Crystalline modifications to pyraclostrobin
04/06/2011EP2303873A1 Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
04/06/2011EP1362852B1 Pyrazole derivative, intermediate therefor, processes for producing these, and herbicide containing these as active ingredient
04/06/2011CN1946680B 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
04/06/2011CN1376146B Solid-state form of celecoxil having enhanced bioavailability
04/06/2011CN102007103A Substituted sulfonic acid amide compounds
04/06/2011CN102000605A Cuprous catalytic initiator Cu2(L)Cl2, preparation method thereof and preparation method of N-heterocyclic aromatized product
04/05/2011US7919633 Process for preparation of celecoxib
04/05/2011US7919632 Method for producing carboxamides
04/05/2011US7919522 Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds
04/05/2011US7919518 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
04/05/2011US7919517 Indazole derivatives
04/05/2011US7919496 5-[4-(2-Trifluoromethylbenzoyl)piperazin-1-yl]-[1,3,4]thiadiazole-2-carboxylic acid ethyl ester; metabolic disorders type II diabetes, impaired glucose tolerance, insulin resistance, obesity, fatty liver, non-alcoholic steatohepatitis, dyslipidemia and metabolic syndrome; cardiovascular disorders
04/05/2011US7918900 Process for the predictable dyeing of keratinous fibers comprising applying at least one composition comprising at least one diamino-N, N-dihydropyrazolone derivative and at least one composition chosen from fundamental and/or golden-highlights compositions
03/2011
03/31/2011WO2011038152A2 Toll-like receptor modulators and uses thereof
03/31/2011WO2011037192A1 Substituted amide compound
03/31/2011WO2011035518A1 Pyrimidine derivatives and analogs, preparation method and use thereof
03/31/2011WO2011017299A3 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
03/31/2011US20110077409 Process for the preparation of certain substituted sulfilimines
03/31/2011US20110077290 Heterocyclic compounds and thrombopoietin receptor activators
03/31/2011US20110077251 Novel 17 beta lupane derivatives
03/31/2011CA2774647A1 Substituted amide compound
03/31/2011CA2774008A1 Toll-like receptor modulators and uses thereof
03/30/2011EP2301534A1 Amino-methyl substituted tetracycline compounds
03/30/2011EP2300437A1 Benzpyrazol derivatives as inhibitors of pi3 kinases
03/30/2011EP2300436A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
03/30/2011EP2300435A2 Heterocyclic compounds as factor ixa inhibitors
03/30/2011EP2300434A1 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors
03/30/2011EP2300417A1 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters
03/30/2011EP2299824A1 Pyrazole derivatives useful as inhibitors of faah
03/30/2011EP2057125B1 Non-nucleoside reverse transcriptase inhibitors
03/30/2011EP1902034B1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
03/30/2011EP1742927B1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
03/30/2011CN1876664B Organometallic complex and organic electroluminescent device using the same
03/30/2011CN101445483B Method for preparing pesticide
03/29/2011US7915293 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases
03/29/2011US7915286 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
03/29/2011CA2618857C 11-beta-hydroxysteroid dehydrogenase-1-inhibitor-diabetes-type 2-1
03/29/2011CA2610354C Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
03/29/2011CA2489276C Tricyclic steroid hormone nuclear receptor modulators
03/29/2011CA2468715C Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/24/2011US20110071291 Hydrazide compound and pesticidal use of the same
03/24/2011US20110071289 Aminopyrazole amide derivative
03/24/2011US20110071282 Process for the preparation of naphthalen-2-yl-pyrazol-3-one intermediates useful in the synthesis of sigma receptor inhibitors
03/24/2011US20110071152 5-membered heterocycle-based p38 kinase inhibitors
03/24/2011US20110070297 Glucokinase activators
03/23/2011EP2298779A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
03/23/2011EP2298775A1 Diazabicyclic central nervous system active agents
03/23/2011EP2298743A1 5-membered heterocycle-based P38 kinase inhibitors
03/23/2011EP2298738A1 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
03/23/2011EP2297112A1 Pyrazole compounds as ccr1 antagonists
03/23/2011EP2297111A2 Method for the production of halogen-substituted 2-(aminomethylidene)-3- oxobutyric acid esters
03/23/2011EP2297110A1 Indane derivatives as ampa receptor modulators
03/23/2011EP2297102A1 Heteroaromatic monoamides as orexinin receptor antagonists
03/23/2011EP2296473A2 Herbicidally effective 4- (3-alkyl sulfinyl benzoyl) pyrazoles
03/23/2011CN101168529B Fipronil, ethiprole and synthesizing method for derivative thereof
03/22/2011US7910747 Phosphonate and phosphinate pyrazolylamide glucokinase activators
03/22/2011US7910746 Haloalkyl carboxamides
03/22/2011US7910601 Heterocyclic aromatic compounds useful as growth hormone secretagogues
03/22/2011CA2513102C Substituted pyrazoles, compositions containing such compounds and methods of use
03/22/2011CA2498091C Sulfonylamino-acetic acid derivatives
03/22/2011CA2497440C Pyrazolopyrimidines as cyclin-dependent kinase inhibitors
03/17/2011US20110065766 Methods of use of antiviral compounds
03/17/2011US20110065667 Phenylpyrazole derivatives
03/17/2011US20110065634 Glucagon receptor antagonists, compositions, and methods for their use
03/16/2011EP2295437A1 Diazabicyclic central nervous system active agents
03/16/2011EP2295429A1 3-((hetero)aryl)-indazoles as Liver X receptor (LXR) and Th-1 inhibitors for the treatment of cardiovascular diseases
03/16/2011EP2295427A1 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
03/16/2011EP2295426A1 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
03/16/2011EP2295413A1 Indazole compounds useful as protein kinase inhibitors
03/16/2011EP2295412A1 Indazole compounds useful as protein kinase inhibitors
03/16/2011EP2295411A1 Pyrazoles as 11-beta-hsd-1
03/16/2011EP2295402A2 Antibacterial agents
03/16/2011EP2294053A2 Glucokinase activators
03/16/2011EP2205562B1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
03/16/2011EP2155685B1 Pyrazole derivatives as p2x7 modulators
03/16/2011EP1703906B1 Immuno inhibitory pyrazolone compounds
03/16/2011EP1699761B1 Cb1 modulator compounds
03/15/2011US7906657 1,5-diphenylpyrazoles II as HSP90 inhibitors
03/15/2011US7906656 Iodopyrazolyl carboxanilides
03/15/2011US7906653 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
03/15/2011US7906556 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
03/15/2011US7906532 Indazole derivatives
03/15/2011US7906235 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
03/15/2011CA2630665C Heterocyclic compound having inhibitory activity on 11-.beta.-hydroxysteroid dehydrogenase type i
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 256